Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    P3 Health Partners Inc. (PIII)

    Price:

    2.12 USD

    ( - -0.10 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    PIII
    Name
    P3 Health Partners Inc.
    Industry
    Medical - Care Facilities
    Sector
    Healthcare
    Price
    2.120
    Market Cap
    6.929M
    Enterprise value
    160.017M
    Currency
    USD
    Ceo
    Aric Coffman
    Full Time Employees
    360
    Website
    Ipo Date
    2021-04-06
    City
    Henderson
    Address
    2370 Corporate Circle

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Aveanna Healthcare Holdings Inc.

    VALUE SCORE:

    5

    Symbol
    AVAH
    Market Cap
    1.508B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare

    2nd position

    Option Care Health, Inc.

    VALUE SCORE:

    9

    Symbol
    OPCH
    Market Cap
    5.176B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare

    The best

    Addus HomeCare Corporation

    VALUE SCORE:

    10

    Symbol
    ADUS
    Market Cap
    1.923B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.053
    P/S
    0.005
    P/B
    -0.371
    Debt/Equity
    -2.711
    EV/FCF
    -0.162
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.014
    Earnings yield
    -18.915
    Debt/assets
    0.074
    FUNDAMENTALS
    Net debt/ebidta
    -0.088
    Interest coverage
    -5.514
    Research And Developement To Revenue
    0
    Intangile to total assets
    0.750
    Capex to operating cash flow
    -0.001
    Capex to revenue
    0.000
    Capex to depreciation
    0.001
    Return on tangible assets
    -0.768
    Debt to market cap
    7.312
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    -0.005
    P/CF
    -0.056
    P/FCF
    -0.056
    RoA %
    -19.171
    RoIC %
    -85.486
    Gross Profit Margin %
    48.179
    Quick Ratio
    0.320
    Current Ratio
    0.320
    Net Profit Margin %
    -9.069
    Net-Net
    -173.012
    FUNDAMENTALS PER SHARE
    FCF per share
    -37.597
    Revenue per share
    442.152
    Net income per share
    -40.100
    Operating cash flow per share
    -37.561
    Free cash flow per share
    -37.597
    Cash per share
    11.540
    Book value per share
    5.792
    Tangible book value per share
    -151.158
    Shareholders equity per share
    -5.718
    Interest debt per share
    29.650
    TECHNICAL
    52 weeks high
    11.300
    52 weeks low
    1.520
    Current trading session High
    2.230
    Current trading session Low
    2.120
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    SG
    Sector
    Healthcare
    Industry
    Medical - Healthcare Plans
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    -0.38099252%
    P/E
    -0.104
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -12.303
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.144
    logo

    Country
    IE
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.401
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.693
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.226
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    -0.77126212%
    P/E
    -0.400
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.095
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -43.825
    DESCRIPTION

    P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

    NEWS
    https://images.financialmodelingprep.com/news/p3-health-partners-nasdaqpiii-vs-tivic-health-systems-nasdaqtivc-critical-20251231.png
    P3 Health Partners (NASDAQ:PIII) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey

    defenseworld.net

    2025-12-31 01:26:54

    P3 Health Partners (NASDAQ: PIII - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership. Analyst Recommendations This is a

    https://images.financialmodelingprep.com/news/financial-survey-mobilehealth-network-solutions-nasdaqmndr-vs-p3-health-partners-20251221.png
    Financial Survey: Mobile-health Network Solutions (NASDAQ:MNDR) vs. P3 Health Partners (NASDAQ:PIII)

    defenseworld.net

    2025-12-21 02:14:49

    P3 Health Partners (NASDAQ: PIII - Get Free Report) and Mobile-health Network Solutions (NASDAQ: MNDR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Volatility and Risk P3 Health

    https://images.financialmodelingprep.com/news/koru-medical-systems-nasdaqkrmd-p3-health-partners-nasdaqpiii-head-to-20251218.png
    KORU Medical Systems (NASDAQ:KRMD) & P3 Health Partners (NASDAQ:PIII) Head to Head Survey

    defenseworld.net

    2025-12-18 01:43:02

    P3 Health Partners (NASDAQ: PIII - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Risk and Volatility P3 Health

    https://images.financialmodelingprep.com/news/p3-health-partners-nasdaqpiii-cvr-medical-otcmktscrrvf-head-to-20251203.png
    P3 Health Partners (NASDAQ:PIII) & CVR Medical (OTCMKTS:CRRVF) Head to Head Contrast

    defenseworld.net

    2025-12-03 01:58:50

    P3 Health Partners (NASDAQ: PIII - Get Free Report) and CVR Medical (OTCMKTS:CRRVF - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Volatility and Risk P3 Health Partners has

    https://images.financialmodelingprep.com/news/p3-expands-footprint-through-joint-venture-with-commonwealth-primary-20251202.jpg
    P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

    businesswire.com

    2025-12-02 16:05:00

    HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners (“P3”) (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed to expand value-based care and enhance support for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina. This partnership brings together two highly aligned organizations with a shared belief in the power of pri.

    https://images.financialmodelingprep.com/news/p3-health-partners-to-present-at-the-noble-capital-20251124.jpg
    P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

    newsfilecorp.com

    2025-11-24 16:05:00

    Henderson, Nevada--(Newsfile Corp. - November 24, 2025) - P3 Health Partners Inc. (NASDAQ: PIII) ("P3"), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Noble Capital Markets' 21st Annual Emerging Growth Equity Conference. Management is scheduled to present at the conference on Wednesday, December 3, 2025, at 3:30 p.m.

    https://images.financialmodelingprep.com/news/p3-health-partners-inc-piii-q3-2025-earnings-call-20251114.jpg
    P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript

    seekingalpha.com

    2025-11-14 09:51:32

    P3 Health Partners Inc. ( PIII ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Aric Coffman - CEO, President & Director Amir Bacchus - Co-Founder, Chief Medical Officer & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Gabriella Gabel Joshua Raskin - Nephron Research LLC Ryan Langston - TD Cowen, Research Division David Larsen - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to the P3 Health's Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded.

    https://images.financialmodelingprep.com/news/p3-health-partners-announces-third-quarter-2025-results-20251113.jpg
    P3 Health Partners Announces Third Quarter 2025 Results

    businesswire.com

    2025-11-13 17:30:00

    HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. “Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model,” said Aric Coffman, CEO of P3. “Medical cost trends, normalized for prior-year adjustments, remain sta.

    https://images.financialmodelingprep.com/news/p3-health-partners-schedules-third-quarter-2025-earnings-release-and-20251021.png
    P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call

    businesswire.com

    2025-10-21 16:05:00

    HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Title & Webc.

    https://images.financialmodelingprep.com/news/p3-health-partners-to-participate-in-the-jefferies-healthcare-services-20250917.png
    P3 Health Partners to Participate in the Jefferies Healthcare Services Conference

    businesswire.com

    2025-09-17 16:05:00

    HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare Services Conference. Management will participate in a fireside chat on Tuesday, September 30, 2025, at 2:25 PM Central Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3.

    https://images.financialmodelingprep.com/news/catalyst-solutions-announces-successful-launch-of-p3-implementation-across-20250825.jpg
    Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States

    prnewswire.com

    2025-08-25 09:30:00

    GREENWOOD VILLAGE, Colo. , Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May 2025.

    https://images.financialmodelingprep.com/news/p3-health-partners-inc-piii-q2-2025-earnings-call-20250814.jpg
    P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript

    seekingalpha.com

    2025-08-14 22:20:31

    P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Amir Bacchus - Co-Founder, Chief Medical Officer & Director Aric Coffman - CEO, President & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Aaron Wukmir - Lake Street Capital Markets, LLC, Research Division David Michael Larsen - BTIG, LLC, Research Division Joshua Richard Raskin - Nephron Research LLC Ryan M. Langston - TD Cowen, Research Division Ryan K.

    https://images.financialmodelingprep.com/news/p3-health-partners-inc-piii-reports-q2-loss-lags-revenue-20250814.jpg
    P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates

    zacks.com

    2025-08-14 18:15:19

    P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago.

    https://images.financialmodelingprep.com/news/p3-health-partners-announces-second-quarter-2025-results-20250814.jpg
    P3 Health Partners Announces Second Quarter 2025 Results

    businesswire.com

    2025-08-14 16:05:00

    HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. “Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan,” said Aric Coffman, CEO of P3. “While we faced prior period headwinds, we've successfully managed medical cost trends to remain flat while imp.

    https://images.financialmodelingprep.com/news/p3-health-partners-schedules-second-quarter-2025-earnings-release-20250731.jpg
    P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

    businesswire.com

    2025-07-31 16:05:00

    HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Sec.